[Abstract Only] Meta-Analysis: Cardiovascular, Mortality, and Kidney Outcomes with GLP-1 Receptor Agonists in Patients with Type 2 Diabetes

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)

Commentary: GLP-1 RA Benefits Extend Beyond MACE Reduction – MedPage Today (free registration required)

Source: EvidenceAlerts